Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to transcatheter/surgical aortic valve replacement
Background
The introduction of transcatheter aortic valve implantation (TAVI) has led to a revival of balloon aortic valvuloplasty (BAV) as treatment of patients with severe aortic stenosis.
Objectives
This study aimed to determine the outcome of BAV as a stand-alone therapy versus BAV as a bridge to TAVI/surgical aortic valve replacement (SAVR).
Objectives
This study aimed to determine the outcome of BAV as a stand-alone therapy versus BAV as a bridge to TAVI/surgical aortic valve replacement (SAVR).
Methods
A cohort of 472 patients underwent 538 BAV procedures. This cohort was divided into group I: BAV alone 387 (81.9%) and group II: BAV as bridge (85; 18.1%) to (65) TAVI or (20) SAVR. Clinical, hemodynamic, and follow-up mortality data were collected.
Results
There was no significant difference between the two groups in the baseline characteristics ( Table 1 ). The mean increase in aortic valve area was 0.39±0.25 in group I and 0.42±0.26 in group II, P =.33. The decrease in mean gradient was 24.1±13.1 in group I and 27.1±13.8 in group II, P =.06. During a median follow-up of 183 days, the mortality rate was 55.2% (214 patients) in group I and 19 (22.3%) in group II during median follow-up of 378 days, P <.001. ( Fig. 1 ).
Table 1
Only gold members can continue reading. Log In or Register to continue
Nov 16, 2017 | Posted by drzezo in CARDIOLOGY | Comments Off on Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to transcatheter/surgical aortic valve replacement
